NCT05182034View on ClinicalTrials.gov

Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

October 17, 2023

Study Completion Date

October 17, 2023

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

SMUP-IA-01(low dose)

A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)

BIOLOGICAL

SMUP-IA-01(mid dose)

A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)

DRUG

Active Control Group Sodium chloride

A single knee administration of Sodium chloride

Trial Locations (5)

Unknown

Seoul Nation University Bundang Hospital, Gyeonggi-do

Gangnam Severance Hospital, Seoul

Korea University Anam Hospita, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

All Listed Sponsors
lead

Medipost Co Ltd.

INDUSTRY